Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Scalp hair folliculitis is hard to diagnose and treat due to various causes and complex classification.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Triple horizontal scalp biopsies are 98% accurate in diagnosing hair loss, better than single biopsies.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

Early diagnosis and less aggressive hair care improve outcomes for Black women with frontal fibrosing alopecia.

FAPD in children may not depend on androgens and should be treated with anti-inflammatory measures and minoxidil.

Some drugs can cause permanent hair loss, though it's rare.

Dermatoscopy helps diagnose hair and scalp disorders in people with Afro-textured hair, but more research is needed for better understanding and treatment.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

The document concludes that correct diagnosis of alopecia types is crucial, scalp biopsies are important, and more research is needed.

Examining scalp biopsies in different ways helps better diagnose hair loss types.

Scalp biopsy helps tell apart permanent and temporary hair loss types and guides treatment.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

Loss of sebaceous glands and inflammation may contribute to the development of scarring alopecia.

Trichoscopy helps tell apart Lichen planopilaris and Frontal fibrosing alopecia from other hair loss conditions.

Dermoscopy is useful for diagnosing lichen planopilaris and certain features may relate to disease duration, age, and gender.

The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.

A woman's hair loss was correctly diagnosed as Lichen planopilaris after initial misdiagnosis, highlighting the usefulness of trichoscopy in diagnosing hair disorders.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Systemic treatments like hydroxychloroquine and cyclosporine A help with Lichen Planopilaris and Frontal Fibrosing Alopecia, but ongoing treatment is needed.

PPAR-γ agonists like pioglitazone may help manage lichen planopilaris but don't fully reverse scarring.

Two women were diagnosed with a rare melanoma that looked like hair loss but was actually a type of skin cancer.

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

CCCA and lichen planopilaris have similar histological features, making them hard to distinguish.

Transverse scalp biopsy sections help diagnose different alopecias by showing hair follicle details and inflammation patterns.

Scarring alopecia, a type of hair loss, is most common in females under 35, often caused by discoid lupus erythematosus and pseudopelade of Brocq. Skin punch biopsy and histopathology are key to identifying its cause.

Hair loss from conditions like LPP and FFA can potentially be reversed with the right treatment.